Back to 
KLP Kapitalforvaltning AS
KLP Kapitalforvaltning AS
FDMT
2 quarters
Position history for KLP Kapitalforvaltning AS's holdings in 4D Molecular Therapeutics, Inc.
No. KLP Kapitalforvaltning exited its FDMT (4D Molecular Therapeutics) position in Q1 2025. Its Q4 2024 13F listed 8,600 shares worth $47,902. KLP Kapitalforvaltning already held FDMT in its Q4 2024 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$47,902
Total Shares Change
-8,600
Quarter-by-Quarter History
Other major holders of FDMT: Viking Global Investors LP, RA Capital Management, L.P., BlackRock Finance, Inc.